Trends to consider in planning an exit strategy Navigating Uncertain Times: IPO Insights for Late-Stage Technology and Life Sciences Companies Read the key findings of our latest IPO report, surveying 200 U.S.-based investors and executives in the life sciences and technology sectors. Navigating Uncertain Times: IPO Insights for Late-Stage Technology and Life Sciences Companies Silicon Valley Venture Capital Survey – Fourth Quarter 2022 Our survey analyzed the terms of 169 venture financings closed in the fourth quarter of 2022 by companies headquartered in Silicon Valley. Silicon Valley Venture Capital Survey – Fourth Quarter 2022 Late-Stage GC Insights: Navigating the Road to an IPO Discover key takeaways from the Tech GC Summit Late-Stage GC Insights: Navigating the Road to an IPO Steps to Consider Now, to Ensure Success on Listing Day Learn the strategic steps a company can take 18+ months prior to listing day, including how to think about public company readiness in today’s uncertain climate. Key Takeaways: Steps to Consider Now, to Ensure Success on Listing Day
Publications Meet Anna Uhls: Bringing FBI and In-House Experience to High-Stakes Investigations September 2, 2026
Publications VDPP v. Volkswagen: Patent Owners Must Plead Licensees’ Compliance with Marking Requirements to Seek Pre-Suit Damages September 2, 2026
Media Coverage Amanda Rose and Chelsea Anderson Talk Biotech IPO Demand with Axios Pro September 1, 2026
Media Coverage Amanda Rose and Ryan Mitteness Featured in Mergermarket on Biotech's 2026 IPO Rebound August 31, 2026
